v3.21.1
Restatement of Previously issued Financial Statements (Tables)
5 Months Ended
Dec. 31, 2020
Prior Period Adjustment [Abstract]  
Summary Of Effect Of Restatement On Financial Statement
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the period, indicated:

    
As Previously
Reported
   
Adjustment
   
As restated
 
Balance Sheet at November 27, 2020
                        
Warrant liability
   $ —       $ 36,549,753     $ 36,549,753  
Total liabilities
 
 
5,680,163

 
 
 
36,549,753
 
 
 
42,229,916
 
Class A ordinary shares subject to possible redemption
     156,885,627       (36,549,754     120,335,873  
Class A ordinary shares
     92       360       442  
Additional
paid-in
capital
     5,007,093       12,232,284       17,239,377  
Accumulated deficit
     (7,611     (12,232,643     (12,240,254
Total Shareholders’ Equity
     5,000,005       1       5,000,006  
       
Balance Sheet at December 31, 2020
                        
Warrant liability
   $ —       $ 36,549,753     $ 36,549,753  
Total liabilities
 
 
5,859,668
 
 
 
36,549,753
 
 
 
42,409,421
 
Class A ordinary shares subject to possible redemption
     156,864,332       (36,549,754     120,314,578  
Class A ordinary shares
     93       360       453  
Additional
paid-in
capital
     5,028,387       12,232,284       17,260,671  
Accumulated deficit
     (28,906     (12,232,643     (12,261,549
Total Shareholders’ Equity
   $ 5,000,005     $ 1     $ 5,000,006  
       
Statement of Operations for the period from July 29, 2020 (inception) through December 31, 2020
                        
Excess of fair value of Private Placement Warrants
 
 
—  
 
 
 
(11,211,642
 
 
(11,211,642
Transaction costs
   $ —       $ (1,021,001   $ (1,021,001
Total other income/(expense)
    
10,751

      (12,232,643     (12,221,892
Net Loss
     (28,906     (12,232,643     (12,261,549
Basic and diluted net loss per share, Class B Ordinary shares
   $ 0.00     $ (3.20     (3.20
       
Statement of Cash Flows for the period from July 29, 2020 (inception) through December 31, 2020
                        
Cash Flows from Operating Activities:
                        
Net loss
   $ (28,906   $ (12,232,643   $ (12,261,549
Excess of fair value of Private Placement Warrants
     —         11,211,642       11,211,642  
Transaction costs
             1,021,001       1,021,001  
Net cash used in operating activities
 
 
(97,168
)
 
 
 
— 
 
 
 
(97,168
)
 
Supplemental disclosure of cash flow information:
                        
Class A ordinary shares subject to possible redemption
     156,864,332       (36,549,754     120,314,578  
Initial classification of warrant liability
 
 
—  
 
 
 
36,549,753
 
 
 
36,549,753